Tissue Repair Ltd (ASX:TRP)
Australia · Delayed Price · Currency is AUD 0.0850
0.00 (0.00%)
Oct 8, 2026, 1:59 PM AEST
Tissue Repair Market Cap
Tissue Repair has a market cap or net worth of 5.14 million as of October 9, 2026. It is the 46,276th most valuable company in the world and the 1,536th biggest in Australia. Its market cap has decreased by 69.64% in one year.
Market Cap
5.14M
Enterprise Value
368.76K
Revenue
2.99M
Global Rank
Country Rank
#1,536 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 18, 2021, Tissue Repair's market cap has decreased from 42.02M to 5.14M, a decrease of -87.77%. That is a compound annual growth rate of -34.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 5.14M | -77.92% |
| Dec 30, 2025 | 23.28M | 37.50% |
| Dec 31, 2024 | 16.93M | 27.27% |
| Dec 29, 2023 | 13.30M | -4.35% |
| Dec 30, 2022 | 13.91M | -57.80% |
| Dec 31, 2021 | 32.95M | -21.58% |
| Nov 18, 2021 | 42.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 14.53M |
| AdAlta | 9.64M |
| Invex Therapeutics | 8.27M |
| Vectus Biosystems | 6.53M |
| Bio-Gene Technology | 6.13M |
| Zelira Therapeutics | 5.95M |
| Biotron | 5.57M |
| Acrux | 5.31M |